Overview
Quanterix offers Simoa technology for ultrasensitive digital biomarker detection of proteins and nucleic acids at sub-femtogram levels, surpassing traditional immunoassays by up to 1000-fold. The company provides automated instruments like HD-X, SR-X, SP-X, and SR-Plex benchtop systems, along with immunoassay kits and custom assay development services. These solutions support precision health research in neurology, oncology, cardiology, immunology, infectious disease, and spatial biology applications.
Frequently asked questions
- What instruments does Quanterix offer for biomarker detection?
- Quanterix provides HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, and SR-Plex benchtop instrument, all enabling ultra-sensitive Simoa technology for proteins and nucleic acids.
- What therapeutic areas does Quanterix support?
- Quanterix focuses on neurology (neurodegeneration, TBI, MS), oncology, cardiology, immunology, infectious disease, inflammation, and spatial biology for early disease detection and precision health.
- Does Quanterix offer custom assay development?
- Yes, Quanterix supports Simoa immunoassay kits and Homebrew Custom Assays, with services available through the Quanterix Accelerator Laboratory for digitized biomarker research and clinical sample testing.